Background illustration for clinical trials search

Paid Clinical Trials Denton

Discover 1,918 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

for
Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma,
Location: Irving TX, Waco TX, Austin TX, The Woodlands TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07227415

Phase1, Phase2, Recruiting

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

for
Advanced/Metastatic Non-Small Cell Lung Cancer,
Location: Irving TX, Garland TX, Houston TX, Sugar Land TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07227298

Phase1, Phase2, Recruiting

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

for
Colorectal Neoplasms
Location: Irving TX, Dallas TX, Houston TX, Pueblo CO,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT05253651

Phase3, Recruiting

Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

for
Pediatric Patients Treated With Radiation Therapy
Location: Irving TX, Oklahoma City OK, Houston TX, St Louis MO,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 0 - 21

Code: NCT01696721

Recruiting

Registry Study for Radiation Therapy Outcomes

for
Neoplasms
Location: Irving TX, Oklahoma City OK, Shreveport LA,
Sponsor: Proton Collaborative Group

Sex: All

Age: 0+

Code: NCT01255748

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up

for
Cancer
Location: Irving TX, Franklin TN, Jacksonville FL
Sponsor: Center for Biomedical Research, LLC

Sex: All

Age: 0+

Code: NCT02070328

Recruiting
New

A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors

for
Solid Tumor
Location: Texas City TX, San Antonio TX, Grand Rapids MI
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07703878

Phase1, Recruiting

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

for
Lung Cancer, Breast Cancer
Location: Irving TX, Birmingham AL, Knoxville TN, Cleveland OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06618287

Phase1, Phase2, Recruiting

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Irving TX, Houston TX, Memphis TN, Grand Island NE,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06162221

Phase1, Phase2, Recruiting

Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors

for
Solid Tumor
Location: Irving TX, Tyler TX, Houston TX, New Orleans LA,
Sponsor: ImmunoGenesis

Sex: All

Age: 18+

Code: NCT06014502

Phase1, Recruiting

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

for
Locally Advanced Unresectable or Metastatic Solid Tumors
Location: Irving TX, Austin TX, San Antonio TX
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

Sex: All

Age: 18+

Code: NCT05458219

Phase1, Recruiting

Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Irving TX, Austin TX, Houston TX, New York NY,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06167317

Phase1, Recruiting

Study of APR-1051 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Irving TX, Houston TX, San Antonio TX, Fairfax VA
Sponsor: Aprea Therapeutics

Sex: All

Age: 18+

Code: NCT06260514

Phase1, Recruiting

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Irving TX, Austin TX, San Antonio TX, Grand Rapids MI,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06804824

Phase1, Recruiting

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

for
Psoriatic Arthritis
Location: Fort Worth TX, The Woodlands TX, Houston TX,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06671496

Phase3, Recruiting

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

for
Cancer
Location: Irving TX, Austin TX, Aurora CO, Atlanta GA, Chicago IL,
Sponsor: MBrace Therapeutics

Sex: All

Age: 18+

Code: NCT06014658

Phase1, Phase2, Recruiting

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Irving TX, Houston TX, St Louis MO, Nashville TN,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06589596

Phase1, Recruiting

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

for
Advanced Solid Tumor, NSCLC (Non-small Cell Lung Cancer),
Location: Irving TX, Houston TX, Denver CO, Rochester MN,
Sponsor: Nuvectis Pharma, Inc.

Sex: All

Age: 18+

Code: NCT05873686

Phase1, Recruiting

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Irving TX, Houston TX, Nashville TN, Rochester MN,
Sponsor: Vividion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05954312

Phase1, Recruiting

Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors

for
Solid Tumors, Adult
Location: Irving TX, San Antonio TX
Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Sex: All

Age: 18+

Code: NCT06504368

Phase1, Recruiting